e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diagnosis and management of pleural and mediastinal diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Laboratorial spectrum of pleural effusions in a tertiary hospital - Five years analysis
L. Antonangelo, B. Silva, M. Acencio, D. Assunção, L. Teixeira, B. Silva, F. Vargas (Sao Paulo, Brazil)
Source:
Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Session:
Diagnosis and management of pleural and mediastinal diseases
Session type:
Thematic Poster Session
Number:
2940
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Antonangelo, B. Silva, M. Acencio, D. Assunção, L. Teixeira, B. Silva, F. Vargas (Sao Paulo, Brazil). Laboratorial spectrum of pleural effusions in a tertiary hospital - Five years analysis. Eur Respir J 2013; 42: Suppl. 57, 2940
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Pleural effusion in a pediatric hospital: epidemiologycal characteristics
Source: Eur Respir J 2007; 30: Suppl. 51, 390s
Year: 2007
Etiology of pleural effusions in a general hospital
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Pleural effusions in medical ICU –prevalence, causes and clinical significance
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Incidence of parapneumonic pleural effusions (PPE) in children. A twenty year experience from a tertiary paediatric department
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Characteristics of tuberculous pleuritis in the last 13 years in our hospital in Alicante
Source: Annual Congress 2006 - Epidemiology and control of tuberculosis
Year: 2006
A review of outcomes of indwelling pleural catheters (IPC) for malignant pleural effusions (MPE) at the Cambridge Pleural unit UK
Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases
Year: 2013
Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Pleural mesothelioma: Our experience in 132 cases
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Tunneled indwelling pleural catheter (TPC) in recurrent malignant pleural effusions: A retrospective study of 230 patients
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Malignant pleural mesothelioma: A retrospective analysis of 32 cases
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Molecular assay for tuberculous pleural effusion
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
A review of pleural fluid TB culture at a large acute UK hospital
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Analysis of 598 patients with pleural empyema: microbiological features and management
Source: Eur Respir J 2005; 26: Suppl. 49, 642s
Year: 2005
Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
The role of a pleural service in optimising pleural disease management
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept